29 Mar 2023
03 Apr 2023
₹ 33.30 Cr
13 Apr 2023
₹ 105 per share
Sotac Pharmaceuticals is in business of manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis and is majorly on principle to principle basis with different marketers.
The IPO comprises of fresh issue of 3,000,000 equity shares which aggregates the issue size to Rs. 33.30 cr.
The objective of the Infinium Pharmachem IPO : The net proceeds from the issue will be used for: • To Meet Working Capital Requirements • Investment in Subsidiary • Upgradation / Construction of Existing /New Building in the Existing Premises • General Corporate Purpose • To meet Public Issue Expenses
The Sotac Pharmaceuticals IPO lot size is 1200 shares. A retail-individual investor can apply for up to 1 lots (1200 shares or ₹133,200).
The allotment date of Sotac Pharmaceuticals IPO is set for 10th April.
Sotac Pharmaceuticals IPO is promoted by Mr. Sharadkumar Dashrathbhai Patel, Mr. Dineshkumar Babulal Gelot, Mr. Vishalkumar Devrajbhai Patel, Mr. Chetankumar Bachubhai Patel, and Mrs. Kiran Baldevbhai Jotania.
Beeline Capital Advisors Limited is the book running lead managers to the issue.